1 / 32

Tyrannosaurus Rx

Tyrannosaurus Rx. Sabrina George Sheliah Vink Katherine King. Company Profile. Pfizer/Merck. Pfizer. Research-based Technology-intensive products Three business segments. Merck. Global research-driven Broad range of products Benefit services. Market Info on Pfizer.

plato-russo
Download Presentation

Tyrannosaurus Rx

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Tyrannosaurus Rx • Sabrina George • Sheliah Vink • Katherine King

  2. Company Profile Pfizer/Merck

  3. Pfizer • Research-based • Technology-intensive products • Three business segments

  4. Merck • Global research-driven • Broad range of products • Benefit services

  5. Market Info on Pfizer • Trading at 43 3/16 • Market Capital is $272,674.02 million • 59.7% of shares held by institutions

  6. Market Info on Merck • Trading at 89 15/16 • Market Capital $206,904.38 million • 53.8% of shares held by institutions

  7. Net Income • Pfizer- • $3,179 million (1999) • Merck- • $5,891 million (1999)

  8. Pfizer vs. Merck “Two of the world’s drug titans are facing off in a war for dominance -- and their strategies couldn’t be more different. In the end, the presidential election may decide who wins.” Fortune Magazine Lee Clifford

  9. Pfizer • American Home Products / Warner Lambert situation • Overbid AHP by more than $10 billion

  10. “Partner of Choice” • Pfizer earned this nickname by promoting drugs for smaller companies

  11. “Predator Of Choice” • Pfizer earned this new nickname after the merger with Warner-Lambert

  12. Merck’s Medco Subsidiary • More than 370 million products delivered yearly • On-line pharmacy business

  13. Merck-Medco • Contracts from unions, corporations, insurance carriers, and HMO’s • Three $80 million high-tech pharmacies

  14. Medco’s Training • Sensitivity training for service reps includes cotton stuffed in ears, gloves and vaseline on glasses.

  15. Strategies

  16. Pfizer’s Strategy • “Free-spending, free marketer” • Unregulated healthcare environment

  17. Merck’s Strategy • Getting deeper into managed care • Medicare reform • “far-reaching inescapable HMO”

  18. Who Will Dominate?

  19. Pfizer’s Competitive Edge • “Marketing machine” • 20,000 sales reps • Spends 39% of revenue on sales and marketing

  20. Merck’s Competitive Edge • Embracing managed care • Concern for uncovered seniors • Employee amenities.

  21. Making A Deal With The Devil • Irked independent pharmacists • Limited distribution of Fosamax • An equity stake in CVS ProCare • Medco’s Your Plan program

  22. Merck’s View Controlling the means of distribution would be a critical advantage in an environment more hostile to profits.

  23. Pfizer’s View “Pfizer is clearly betting that the medical environment doesn’t change that much-that people will continue to pay up for drugs.”

  24. Sales Force

  25. Pfizer’s Sales Force • 20,000 sales reps • Each rep averages 459 visits to doctors • Very aggressive approach

  26. Merck’s Sales Force • 11,000 sales reps • Salespeople are “collegial,” “responsible,” and “less aggressive”

  27. Political Effects

  28. Bush Administration • Pfizer benefits • Merck suffers

  29. Gore Administration • Merck profits • Pfizer takes a dive

  30. Conclusion

  31. Which one is better? • Based on election • Our vote is for Merck

  32. Thank You! • Don’t forget to vote

More Related